Urology Device Market
Urology Device Market Study by Dialysis Devices, Endoscopes, Lasers & Lithotripsy Devices, Robotic Systems, Endovision Systems, Peripheral Instruments, and Urodynamic Systems from 2024 to 2034
Analysis of Urology Device Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Urology Device Market Outlook (2024 to 2034)
The global urology device market has been approximated at a value of US$ 13.07 billion in 2024 and is projected to increase at a CAGR of 6.2% to reach US$ 23.8 billion by the end of 2034.
Urology is the branch of medicine that deals with diseases associated with the male and female urinary tract and reproductive system. These diseases include bladder control problems, kidney stones, urinary tract infections, prostate problems, cancer, and others. Urology devices are utilized in the diagnosis and surgical treatment of these diseases, and hence, the field is also known as genitourinary surgery. Some of the common urology diagnostic devices are cystoscopy, ureteroscopy, urodynamic testing, dialysis devices, endoscopes, laser & lithotripsy devices, and endovision systems.
Global statistics of the rising geriatric population are alarming, which, in turn, is expected to increase the cases of age-associated chronic diseases. Urologic diseases arise from the urinary system itself, or they could be secondary to an illness or due to any underlying disease. There has been a dramatic rise in secondary urologic disease cases associated with chronic disorders such as diabetes. As such, demand for urology devices is estimated to increase at a high pace over the coming years.
Rising trend of robotics and automation in urology devices will attract public and private funding for R&D. FDA approvals of recent robotic surgical treatments are encouraging the utilization of urology devices. The Food and Drug Administration (FDA) recently approved the robotic surgical system of Intuitive. Such approvals are encouraging several other robotic innovations in the pipeline.
- North America is projected to account for 33.9% of the global urology device market share by 2034.
- The Western European urology device market size is evaluated at US$ 2.77 billion in 2024.
| Report Attribute | Detail |
|---|---|
| Urology Device Market Size (2024E) | US$ 13.07 Billion |
| Forecasted Market Value (2034F) | US$ 23.8 Billion |
| Global Market Growth Rate (2024 to 2034) | 6.2% CAGR |
| South Korea Market Value (2034F) | US$ 1.07 Billion |
| Dialysis Device Demand Growth Rate (2024 to 2034) | 6.6% CAGR |
| Key Companies Profiled | Siemens AG; Baxter International Inc.; Medtronic; Abbott; Boston Scientific Corporation; Stryker Corporation; Olympus Corporation; Johnson & Johnson Services Inc.; Fresenius Medical Care AG & Co. KGaA; Cook Medical Inc.; Cardinal Health; Intuitive Surgical; KARL STORZ GmbH & Co. KG; Richard Wolf GmbH; Dornier MedTech. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How are Technological Advancements Driving Up Sales of Urology Devices?
“Developments in Treatment Options Increasing Chances of Quick Recovery”
Although the treatment of prostate cancer depends on the diagnosed stage, a particular diagnosis has multiple options for treatment. Urolithiasis or kidney stones are treated with kidney stone management devices such as endoscopy, cystoscopy, and lasers & lithotripsy devices. The urodynamic system is mostly utilized for the treatment of bladder leakage problems.
In the case of prostate cancer, surgical removal, brachytherapy, and radiation therapy are the most utilized treatments. Treatment selection is witnessing evolution with the development of innovations in robotic-assisted prostatectomy and proton beam radiation therapy. Manufacturers of medical devices are collaborating with research institutions to develop advanced urology devices due to the rising prevalence of end-stage renal diseases, chronic kidney diseases, and urethral malignancies.
- In February 2023 Ethicon, a subsidiary of Johnson & Johnson MedTech Company, announced the launch of the MONARCH™ Platform for Urology, the first patient-receiving robotic-assisted device for removal of kidney stones.
Thus, introduction of technologically advanced devices is one of the notable urology device market trends set to boost the profits of suppliers. Such promising advancements are increasing the adoption of cutting-edge urology devices.
“Minimally Invasive Treatment Preferred and Effective Option for Urology-related Disorders”
With the rapidly transforming medical sector, there is a growing preference for minimally invasive surgical treatments that involve one or more small incisions, quicker recovery times, and less discomfort as opposed to conventional surgeries. Innovations in minimally invasive treatment designs to treat prostate cancer are leading to efficient results.
One such example is High-Intensity Focused Ultrasound (HIFU), in which high-intensity ultrasound waves are used to destroy cancer cells while protecting the surrounding healthy tissues. This treatment has better visibility and control during surgery and significantly reduces recovery time. Another example is of Urolift system for the treatment of benign prostate hyperplasia (BPH). This is also a minimally invasive treatment without a catheter, which allows patients to return home the same day.
What Challenges are Brought Up by Technological Advancements?
“High Cost of Advanced Urology Devices and Adverse Effects Associated with Cystoscopies”
Although innovative treatments seem promising, their newness poses a dearth of knowledge in terms of long-term success, reliability, and possible side effects. This has been creating significant hurdles in the quick adoption of advanced urology devices by medical practitioners and patients. High cost of medical devices and stringent regulatory requirements for device approvals are emerging as potential challenges to urology device market growth. Improper use of cystoscopies is leading to issues such as infections, urinary incontinence, bleeding, and bladder perforation, which is further expected to reduce their use.
- According to an article published by Mayo Clinic on cystoscopy, some patients after cystoscopy can witness the inability to urinate, bright red and heavy blood clots in urine, high fever, and abdominal pain.
- As per an article by Nature, office cystoscopy associated with urinary tract infection (UTI) can be 10% to 20%.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Start-up Ecosystem
- RenalTracker is a Netherlands-based start-up that offers a software application that helps users slow down or halt the progression of chronic kidney disease.
- Kite Medical, an Irish start-up, offers a non-invasive, cost-effective, and trauma-free system for the detection of kidney reflux in children through the use of electrical impedance tomography.
Country-wise Analysis
Why are United States-based Urology Device Manufacturers Experiencing High Growth in Their Profits?
“Kidney Disorders One of the Fast-Growing Noncommunicable Diseases among Americans”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 4.06 Billion |
| Growth Rate (2024 to 2034) | 6.9% CAGR |
| Projected Value (2034F) | US$ 7.96 Billion |
Kidney disease is increasing at an alarming rate in the United States. Increasing number of hospitalizations for the diagnosis and treatment of end-stage renal disease (ESRD) and acute kidney injury (AKI) are driving up the adoption of advanced urology technologies in the country.
- According to the American Society of Cancer (ASC), after lung cancer, prostate cancer is the most common cause of cancer death among American men.
- According to an article by American Kidney Fund 2024, around 35.5 million Americans are living with kidney disorders.
- According to the same source, more than 557,000 Americans are on dialysis, and 9 out of 10 are unaware of their kidney-related disorders.
The urologic disease diagnosis and treatment scenario in the United States is complemented by the presence of leading manufacturers of urology devices, including Boston Scientific, Baxter, CR Bard, and Intuitive Surgical. Thus, the country is expected to observe rising demand and supply of urology devices over the coming years.
How is Rising Prevalence of Diabetes Increasing Need for Innovative Urology Devices in India?
“Type 2 Diabetic Patients Have Double Chances of Suffering from Kidney Stones”
| Attribute | India |
|---|---|
| Market Value (2024E) | US$ 637.8 Million |
| Growth Rate (2024 to 2034) | 9.4% CAGR |
| Projected Value (2034F) | US$ 1.55 Billion |
Development of kidney stones is attributed to dietary and lifestyle changes, drinking less water, and some environmental factors. Asia has divergent climates and cultures that make the characteristic prevalent and lead to the surge in the cases of kidney stones.
Further, development of renal stones has been observed to be associated with systemic diseases such as type 2 diabetes mellitus, obesity, dyslipidemia, and hypertension. Southeast Asian countries, notably India, are facing the diabetes epidemic, especially type 2 diabetes, which, in turn, is adding to the incidence of renal stone diagnosis.
- According to the National Center of Biotechnology Information, after China, India holds a leading position in the global diabetes epidemic.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Analysis
Which Disease Type is Supporting Sales Growth of Urology Devices?
“Rising Cases of Kidney Diseases Worldwide Pushing Adoption of Advanced Urology Devices”
| Attribute | Kidney Diseases |
|---|---|
| Segment Value (2024E) | US$ 7.42 Billion |
| Growth Rate (2024 to 2034) | 6.2% CAGR |
| Projected Value (2034F) | US$ 13.52 Billion |
- According to a report by Nature 2024, around 850 million people worldwide are living with kidney disease.
Demand for advanced urology devices is being driven by the rising prevalence of kidney diseases across the world. Patients living with kidney disorders primarily prefer dialysis and minimally invasive surgeries.
The geriatric population, who are prone to chronic illnesses such as high blood pressure and diabetes, are more susceptible to kidney diseases. BP and diabetes are key reasons leading to kidney disorders among the aging population. Thus, rising prevalence of kidney disorders is driving the adoption of innovative urology technologies.
Why Do Patients Prefer Hospitals and Clinics for Diagnosis and Treatment?
“Hospitals and Clinics Provide Advanced Treatment and Patient-Centric Care”
| Attribute | Hospitals and Clinics |
|---|---|
| Segment Value (2024E) | US$ 6.87 Billion |
| Growth Rate (2024 to 2034) | 5.9% CAGR |
| Projected Value (2034F) | US$ 12.25 Billion |
- Hospitals and clinics are set to capture 51.5% of the global market share by 2034.
Most target patients prefer taking treatment from hospitals and specialty clinics due to the presence of advanced healthcare systems and technologies. These healthcare facilities offer advanced services for the diagnosis and treatment of urological disorders. Rising popularity of minimally invasive procedures is further positioning hospitals and clinics to be prime treatment providing infrastructures.
Competitive Landscape
Key players in the global urology device market are coming up with innovative marketing ideas to boost their product sales. Majority of the companies are targeting specific consumers with high demand to lead the market by having early entry in segments. They are continuously focusing on advancing their products and are also collaborating with research institutions to introduce technologically advanced devices.
- In March 2024, Intuitive received FDA clearance for the Fifth-Generation Robotic System 'da Vinci 5'.
- In January 2022, Ascend Wellness Holdings, a dialysis testing laboratory, signed a strategic partnership with Siemens Healthineers to expand the testing capacity at Ascend’s new laboratory in California
- In November 2021, a Taiwan-based company, Brain Navi Biotechnology, received CE (Conformité Européenne) mark for its robotic-assisted surgical robot NaoTrac.
Fact.MR provides detailed information about the price points of key manufacturers of urology devices positioned across the world, sales growth, production capacity, and speculative technological expansion, in the recently updated market report.
Key Segments of Urology Device Market Research
-
By Product Type :
- Dialysis Devices
- Endoscopes
- Lasers & Lithotripsy Devices
- Robotic Systems
- Endovision Systems
- Peripheral Instruments
- Urodynamic Systems
-
By Disease :
- Kidney Diseases
- Cancer & BPH
- Pelvic Organ Prolapse
- Others
-
By End User :
- Hospitals & Clinics
- Dialysis Centers
- Others
-
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Disease 6.2. Product Type 6.3. End User 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Disease 7.1. Kidney Diseases 7.2. Cancer & BPH 7.3. Pelvic Organ Prolapse 7.4. Others 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product Type 8.1. Dialysis Devices 8.2. Endoscopes 8.3. Lasers & Lithotripsy Devices 8.4. Robotic Systems 8.5. Endovision Systems 8.6. Peripheral Instruments 8.7. Urodynamic Systems 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User 9.1. Hospitals & Clinics 9.2. Dialysis Centers 9.3. Others 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia & Pacific 10.7. Middle East & Africa 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Sales Forecast 2024 to 2034 by Disease, Product Type, End User, and Region for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Siemens AG 20.2. Baxter International Inc. 20.3. Medtronic 20.4. Abbott 20.5. Boston Scientific Corporation 20.6. Stryker Corporation 20.7. Olympus Corporation 20.8. Johnson & Johnson Services Inc. 20.9. Fresenius Medical Care AG & Co. KGaA 20.10. Cook Medical Inc. 20.11. Cardinal Health 20.12. Intuitive Surgical 20.13. KARL STORZ GmbH & Co. KG 20.14. Richard Wolf GmbH 20.15. Dornier MedTech 21. Assumptions and Acronyms Diseased 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Western Europe Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 41: Western Europe Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 42: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 43: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 44: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 45: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 46: Western Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 47: Western Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 48: Western Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 49: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 50: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: Eastern Europe Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 53: Eastern Europe Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 54: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 55: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 56: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 57: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 58: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 59: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 60: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 61: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 62: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: East Asia Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 65: East Asia Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 66: East Asia Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 67: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 68: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 69: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 70: East Asia Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 71: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 73: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 74: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 77: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 78: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 79: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 80: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 81: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 82: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 83: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 84: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 85: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 86: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 87: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 88: MEA Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 89: MEA Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 90: MEA Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 91: MEA Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 92: MEA Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 93: MEA Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 94: MEA Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 95: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 96: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 49: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 50: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 52: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Western Europe Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 57: Western Europe Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 58: Western Europe Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 59: Western Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 60: Western Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 61: Western Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 62: Western Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 63: Western Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 64: Western Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 66: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 67: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 68: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 69: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 70: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 71: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 72: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: Eastern Europe Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 74: Eastern Europe Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 75: Eastern Europe Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 76: Eastern Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 77: Eastern Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 78: Eastern Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 79: Eastern Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 80: Eastern Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 81: Eastern Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 82: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 83: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 84: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 85: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 86: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 87: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 88: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 89: East Asia Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 90: East Asia Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 91: East Asia Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 92: East Asia Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 93: East Asia Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 94: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 95: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 96: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 97: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 98: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 99: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 100: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 101: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 102: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 103: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 104: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 105: South Asia & Pacific Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 106: South Asia & Pacific Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 107: South Asia & Pacific Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 108: South Asia & Pacific Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 109: South Asia & Pacific Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 110: South Asia & Pacific Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 111: South Asia & Pacific Market Share and BPS Analysis by End User, 2024 & 2034
Figure 112: South Asia & Pacific Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 113: South Asia & Pacific Market Attractiveness Analysis by End User, 2024 to 2034
Figure 114: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 115: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 116: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 117: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 118: MEA Market Share Analysis by Country, 2024 & 2034
Figure 119: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 120: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 121: MEA Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 122: MEA Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 123: MEA Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 124: MEA Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 125: MEA Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 126: MEA Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 127: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 128: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 129: MEA Market Attractiveness Analysis by End User, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the urology device market?
The global urology device market is estimated at US$ 13.07 billion in 2024.
What is the future of urology devices?
Sales of urology devices are foreseen to rise at a CAGR of 6.2% from 2024 to 2034.
How much are the projected sales of urology devices for 2034?
The market for urology devices is forecasted to reach US$ 23.8 billion by 2034.
Is North America a big market for urology device manufacturers?
North America is estimated to account for 35.4% of the global market share in 2024.
How is the market for urology devices faring in India?
Demand for urology devices in India is projected to rise at a CAGR of 9.4% during the next 10 years.
Which type of urology device is most widely demanded?
Sales of dialysis devices are projected to reach US$ 14.01 billion for 2034.
Who are the leading producers of urology devices?
Well-known manufacturers are Baxter International Inc., Medtronic, Siemens AG, Abbott, Boston Scientific Corporation, and Stryker Corporation.
What are the new technologies for urology?
Robotic surgery is one of the trending minimally invasive technologies in this space.
Urology Device Market